SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-20-000073
Filing Date
2020-05-18
Accepted
2020-05-18 16:08:13
Documents
4
Period of Report
2020-05-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-202005188xkdoc.htm 8-K 30811
2 PRESS RELEASE pdli-202005188xkex991.htm EX-99.1 14957
3 INFORMATION SHEET pdli-202005188xkex992.htm EX-99.2 52986
4 pdllogoa35.jpg GRAPHIC 123123
  Complete submission text file 0000882104-20-000073.txt   269367
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 20889589
SIC: 2836 Biological Products, (No Diagnostic Substances)